IF 9.6 1区 医学 Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY
Scott J. Moeller, Jodi J. Weinstein, Benjamin Varnas, Olivia Orellano, Roberto Gil, Greg Perlman, Sameera Abeykoon, Jiayan Meng, Ingrid Oprea, Bao Hu, Wenchao Qu, Mark Slifstein, Anissa Abi-Dargham
{"title":"Cholinergic tone abnormalities and relationships with smoking severity in human cigarette smokers: exploratory positron emission tomography study using [18F]VAT","authors":"Scott J. Moeller, Jodi J. Weinstein, Benjamin Varnas, Olivia Orellano, Roberto Gil, Greg Perlman, Sameera Abeykoon, Jiayan Meng, Ingrid Oprea, Bao Hu, Wenchao Qu, Mark Slifstein, Anissa Abi-Dargham","doi":"10.1038/s41380-025-02985-3","DOIUrl":null,"url":null,"abstract":"<p>Nicotine acts on the brain cholinergic system to drive the rewarding effects of cigarettes and perpetuate smoking. Prior studies in human smokers have used positron emission tomography (PET) to characterize differences in postsynaptic nicotinic acetylcholine receptors (nAChRs). However, preclinical studies indicate that nicotine also modulates presynaptic cholinergic targets that have implications for transmission, including the vesicular acetylcholine transporter (VAChT). To date, there is a paucity of studies imaging presynaptic targets in human smokers. We conducted an initial PET neuroimaging study with [<sup>18</sup>F]VAT, which indexes VAChT availability (presynaptic marker of cholinergic tone), in 12 healthy smokers and 13 demographically-matched healthy non-smokers. We tested for group differences in VAChT availability, measured as total distribution volume (V<sub>T</sub>), in the striatum (main region of interest) and in multiple cortical and subcortical extrastriatal regions. Within smokers, we also tested correlations between VAChT availability and indices of smoking chronicity and tobacco self-administration. Smokers had higher [<sup>18</sup>F]VAT V<sub>T</sub> than non-smokers in multiple cortical and subcortical regions (<i>p</i> &lt; 0.05<sub>uncorrected</sub>). There were no group differences in the striatum. Within smokers, V<sub>T</sub> in the dorsolateral prefrontal and temporal cortices was positively correlated with smoking chronicity (<i>p</i> &lt; 0.05<sub>corrected</sub>). This study provides first-line evidence of presynaptic cholinergic differences between smokers and non-smokers, such that VAChT is upregulated in smokers and associated with chronicity. Future studies with larger samples are needed to verify these initial effects. With confirmation, these findings could inform the development of new VAChT-targeting therapeutics that could potentially benefit smokers who have been unable to quit with currently available treatments.</p>","PeriodicalId":19008,"journal":{"name":"Molecular Psychiatry","volume":"52 1","pages":""},"PeriodicalIF":9.6000,"publicationDate":"2025-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular Psychiatry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s41380-025-02985-3","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

尼古丁作用于大脑胆碱能系统,推动香烟的奖励效应并使吸烟者长期吸烟。之前对人类吸烟者的研究使用正电子发射断层扫描(PET)来描述突触后烟碱乙酰胆碱受体(nAChRs)的差异。然而,临床前研究表明,尼古丁还能调节突触前胆碱能靶点,包括囊泡乙酰胆碱转运体(VAChT),从而对传导产生影响。迄今为止,有关人类吸烟者突触前靶点成像的研究还很少。我们使用[18F]VAT对 12 名健康吸烟者和 13 名与人口统计学相匹配的健康非吸烟者进行了初步的 PET 神经成像研究,[18F]VAT 可指示 VAChT 的可用性(胆碱能张力的突触前标记)。我们检测了纹状体(主要研究区域)以及多个皮质和皮质下叶外区域中以总分布容积(VT)衡量的 VAChT 可用性的群体差异。在吸烟者中,我们还检测了 VAChT 可用性与长期吸烟指数和烟草自我管理之间的相关性。在多个皮层和皮层下区域,吸烟者的[18F]VAT VT高于非吸烟者(p < 0.05未校正)。纹状体没有组间差异。在吸烟者中,背外侧前额叶和颞叶皮层的 VT 与长期吸烟呈正相关(p < 0.05corrected)。这项研究提供了吸烟者与非吸烟者突触前胆碱能差异的第一线证据,即吸烟者的 VAChT 上调,并与长期吸烟有关。今后需要进行更大规模的样本研究,以验证这些初步影响。如果得到证实,这些发现将有助于开发新的以VAChT为靶点的治疗方法,从而使那些无法通过现有治疗方法戒烟的吸烟者从中受益。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Cholinergic tone abnormalities and relationships with smoking severity in human cigarette smokers: exploratory positron emission tomography study using [18F]VAT

Cholinergic tone abnormalities and relationships with smoking severity in human cigarette smokers: exploratory positron emission tomography study using [18F]VAT

Nicotine acts on the brain cholinergic system to drive the rewarding effects of cigarettes and perpetuate smoking. Prior studies in human smokers have used positron emission tomography (PET) to characterize differences in postsynaptic nicotinic acetylcholine receptors (nAChRs). However, preclinical studies indicate that nicotine also modulates presynaptic cholinergic targets that have implications for transmission, including the vesicular acetylcholine transporter (VAChT). To date, there is a paucity of studies imaging presynaptic targets in human smokers. We conducted an initial PET neuroimaging study with [18F]VAT, which indexes VAChT availability (presynaptic marker of cholinergic tone), in 12 healthy smokers and 13 demographically-matched healthy non-smokers. We tested for group differences in VAChT availability, measured as total distribution volume (VT), in the striatum (main region of interest) and in multiple cortical and subcortical extrastriatal regions. Within smokers, we also tested correlations between VAChT availability and indices of smoking chronicity and tobacco self-administration. Smokers had higher [18F]VAT VT than non-smokers in multiple cortical and subcortical regions (p < 0.05uncorrected). There were no group differences in the striatum. Within smokers, VT in the dorsolateral prefrontal and temporal cortices was positively correlated with smoking chronicity (p < 0.05corrected). This study provides first-line evidence of presynaptic cholinergic differences between smokers and non-smokers, such that VAChT is upregulated in smokers and associated with chronicity. Future studies with larger samples are needed to verify these initial effects. With confirmation, these findings could inform the development of new VAChT-targeting therapeutics that could potentially benefit smokers who have been unable to quit with currently available treatments.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Molecular Psychiatry
Molecular Psychiatry 医学-精神病学
CiteScore
20.50
自引率
4.50%
发文量
459
审稿时长
4-8 weeks
期刊介绍: Molecular Psychiatry focuses on publishing research that aims to uncover the biological mechanisms behind psychiatric disorders and their treatment. The journal emphasizes studies that bridge pre-clinical and clinical research, covering cellular, molecular, integrative, clinical, imaging, and psychopharmacology levels.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信